Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

METSÄ TISSUE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4%   Bankruptcy risk   5.8% 3.8% 15.8% 5.0% 5.3% 6.4% 9.1% 8.9%   Credit score (0-100)   41 51 11 43 41 37 27 28   Credit rating   BBB BBB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   22,259 12,318 11,892 14,609 11,490 10,566 0.0 0.0   EBITDA   11,080 2,236 2,235 2,826 2,039 1,753 0.0 0.0   EBIT   10,992 2,236 2,235 2,826 2,039 1,753 0.0 0.0   Pre-tax profit (PTP)   10,979.2 2,226.2 2,244.3 2,875.7 2,439.3 2,164.4 0.0 0.0   Net earnings   8,436.7 1,721.0 1,731.0 2,208.1 1,868.9 1,672.3 0.0 0.0   Pre-tax profit without non-rec. items   10,979 2,226 2,244 2,876 2,439 2,164 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   16,585 9,906 9,937 10,445 10,114 9,936 4,436 4,436   Interest-bearing liabilities   4,126 3,010 3,749 606 1,874 902 0.0 0.0   Balance sheet total (assets)   24,936 16,224 16,610 14,333 14,641 12,549 4,436 4,436   Net Debt   4,124 3,009 3,748 605 1,873 901 -4,436 -4,436     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   22,259 12,318 11,892 14,609 11,490 10,566 0.0 0.0   Gross profit growth   -31.0% -44.7% -3.5% 22.8% -21.3% -8.0% -100.0% 0.0%   Employees   17 15 14 14 12 12 0 0   Employee growth %   0.0% -11.8% -6.7% 0.0% -14.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   24,936 16,224 16,610 14,333 14,641 12,549 4,436 4,436   Balance sheet change%   -17.7% -34.9% 2.4% -13.7% 2.2% -14.3% -64.7% 0.0%   Added value   11,080.5 2,235.7 2,235.1 2,825.7 2,039.2 1,752.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -177 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   49.4% 18.1% 18.8% 19.3% 17.7% 16.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   39.8% 10.9% 13.7% 18.6% 16.9% 16.0% 0.0% 0.0%   ROI %   49.1% 13.1% 15.3% 21.0% 21.3% 19.1% 0.0% 0.0%   ROE %   41.9% 13.0% 17.4% 21.7% 18.2% 16.7% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   66.5% 61.1% 59.8% 72.9% 69.1% 79.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   37.2% 134.6% 167.7% 21.4% 91.8% 51.4% 0.0% 0.0%   Gearing %   24.9% 30.4% 37.7% 5.8% 18.5% 9.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.6% 0.3% 0.3% 0.4% 0.8% 0.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   3.1 2.6 0.0 3.7 3.2 4.8 0.0 0.0   Current Ratio   3.1 2.6 0.0 3.7 3.2 4.8 0.0 0.0   Cash and cash equivalent   1.2 1.2 1.2 1.2 1.2 1.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   16,970.7 9,905.7 16,610.3 10,444.8 10,113.7 9,936.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   652 149 160 202 170 146 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   652 149 160 202 170 146 0 0   EBIT / employee   647 149 160 202 170 146 0 0   Net earnings / employee   496 115 124 158 156 139 0 0